HealthLynked Reports First Quarter 2019 Financial Results and Recent Revenue Improvement

NEXT STORY
BeyondSpring’s Rationale for the Plinabulin-Neulasta Combination for Neutropenia Prevention Accepted as Abstracts at 2019 ASCO Annual Meeting
PREV STORY
Résultats positifs de la plateforme ciblée en oncologie de Theratechnologies présentés en ligne à ASCO
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

UroGen Pharma to Host Third Quarter 2017 Financial Results Conference Call on Tuesday, November 14, 2017

RA’ANANA, Israel and NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. ...

author_avatar
NASDAQ Market News

VBL Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

TLC Highlights Findings in Abstract Accepted at Osteoarthritis Research Society International (OARSI) 2020 and Published in Osteoarthritis and Cartilage

author_avatar
NASDAQ Market News